Your World of Legal Intelligence
 Australia | 1-800-335-6202

Alphapharm Pty Ltd v H Lundbeck A/S

Judgment Cited authorities 63 Cited in 18 Precedent Map Related
Vincent
JurisdictionAustralia Federal only
Judgment Date24 April 2008
Neutral Citation[2008] FCA 559
CourtFederal Court
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
17 cases
  • H. Lundbeck A/S v Sandoz Pty Ltd CNS Pharma Pty Ltd v Sandoz Pty Ltd
    • Australia
    • High Court
    • 9 March 2022
    ...1952 Act. 62 Australia, Senate, Patents Amendment Bill 1989, Explanatory Memorandum at 6 [27]. 63 Alphapharm Pty Ltd v H Lundbeck A/S (2008) 76 IPR 618. 64 H Lundbeck A/S v Alphapharm Pty Ltd (2009) 177 FCR 65 Alphapharm Pty Ltd v H Lundbeck A/S (2011) 92 IPR 628. 66 Re Aspen Pharma Pty Ltd......
  • Axent Holdings Pty Ltd t/a Axent Global v Compusign Australia Pty Ltd
    • Australia
    • Federal Court
    • 25 September 2020
    ...90 IPR 457 Alcan (NT) Alumina Pty Ltd v Commissioner of Territory Revenue [2009] HCA 41; 239 CLR 27 Alphapharm Pty Ltd v H Lundbeck A/S [2008] FCA 559; 76 IPR 618 Anaesthetic Supplies Pty Ltd v Rescare Ltd (1994) 50 FCR 1; 122 ALR 141; 28 IPR 383 Apotex Pty Ltd v Les Laboratoires Servier (N......
  • Citrus Queensland Pty Ltd v Sunstate Orchards Pty Ltd (No 7)
    • Australia
    • Federal Court
    • 5 September 2008
    ...42 FCR 470 cited Adelaide Petroleum NL & Ors v Poseidon Limited & Ors (1988) 10 ATPR 40-901 cited Alphapharm Pty Ltd v H Lundbeck A/S [2008] FCA 559 cited Amadio Pty Ltd v Henderson (1998) 81 FCR 149 cited Arnotts Ltd v Trade Practices Commission (1990) 24 FCR 313 cited Australian Competiti......
  • Alphapharm Pty Ltd v H Lundbeck A/S
    • Australia
    • High Court
    • 5 November 2014
    ...below) and conforms with the descriptions given to both in complex, related patent litigation. See Alphapharm Pty Ltd v H Lundbeck A/S (2008) 76 IPR 618; H Lundbeck A/S v Alphapharm Pty Ltd (2009) 177 FCR 3 See Act, ss 207, 209 and 210. 4Alphapharm Pty Ltd v H Lundbeck A/S (2011) 92 IPR 628......
    • Request a trial to view additional results
1 firm's commentaries
  • Differences in Trans-Tasman patent law: extension of term for pharmaceuticals
    • Australia
    • Mondaq Australia
    • 11 July 2013
    ...the patentee who will generally sponsor inclusion on the ARTG; this marks the expected beginning of their exploitation (as per Alphapharm [2008] FCA 559 and 76 IPR 618). The Delegate then noted an untenable "double edged sword" argument in Pfizer (No.2) [2006] FCA 1176 and 69 IPR 525 wherei......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT